Palvella Therapeutics (PVLA) Net Equity Issued and Repurchased (2014 - 2026)
Palvella Therapeutics (PVLA) reported Net Equity Issued and Repurchased of $230 million for Q1 2026, compared with $67,000 a year earlier.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Net Equity Issued and Repurchased (2014 - 2026) Analysis & Trends
For FY2025, Palvella Therapeutics posted Net Equity Issued and Repurchased of $763,000, down 98.7% from FY2024.
- Net Equity Issued and Repurchased has a five-year compound annual growth rate of -39.8% (FY2020 to FY2025).
- By year, Net Equity Issued and Repurchased came in at $60 million in FY2024, $6.92 million in FY2022 (-81.9%) and $38.19 million in FY2021 (+296.8%).
- The Q1 2026 figure ranks as the highest quarterly Net Equity Issued and Repurchased in data going back to Q2 2013.
- Per Business Quant data, the three quarters before Q1 2026 came in at $105,000 (Q4 2025), $242,000 (Q3 2025) and $349,000 (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Palvella Therapeutics | 2.47 Bn | 2.23 Bn | - | 452,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 452,000.00 |
| Jun 30, 2026 | 1.28 Mn |
| Mar 31, 2026 | 230.96 Mn |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 242,000.00 |
| Jun 30, 2025 | 349,000.00 |
| Mar 31, 2025 | 67,000.00 |
| Dec 31, 2024 | 60.00 Mn |
| Dec 31, 2023 | -19.78 Mn |
| Jun 30, 2023 | 19.78 Mn |
| Dec 31, 2022 | 93,000.00 |
| Sep 30, 2022 | 282,000.00 |
| Jun 30, 2022 | 281,000.00 |
| Mar 31, 2022 | 6.56 Mn |
| Dec 31, 2021 | 4.90 Mn |
| Sep 30, 2021 | 21.92 Mn |
| Jun 30, 2021 | 22.62 Mn |
| Mar 31, 2021 | 9.69 Mn |
| Dec 31, 2020 | 75,000.00 |
| Sep 30, 2020 | 9.62 Mn |
API Access
Palvella Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();